{"nct_id":"NCT05002569","title":"A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma","status":"TERMINATED","status_verified_date":"2025-05","start_date":"2021-10-19","start_date_type":"ACTUAL","primary_completion_date":"2024-12-16","primary_completion_date_type":"ACTUAL","completion_date":"2025-04-02","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}